Expert guidance at the intersection of ophthalmology, biotech, and medical training.

Morgan Biomed Consulting integrates clinical ophthalmology, gene and cell therapy expertise, and academic experience to help companies, institutions, and trainees make better decisions. We support ophthalmic innovation, advanced therapeutic development, and medical training applicants with clear, structured, and data-driven advice.

Richard A. Morgan, MD, PhD

Dr. Morgan is an ophthalmologist and physician-scientist with experience in cataract surgery, retinal disease, gene and cell therapy research, and medical education. Morgan Biomed Consulting was created to connect that experience to teams and trainees who need clear, practical guidance.

What we focus on

Ophthalmology consulting

Strategic input on clinical workflows, device and procedure adoption, trial design support, and market positioning across cataract, retina, glaucoma, cornea, and imaging technologies.

Gene and cell therapy strategy

Scientific and translational guidance for gene and cell therapy programs, including vector and cell platform evaluation, protocol refinement, and academic–industry alignment.

Medical training advising

Structured support for applicants to medical school and residency, with a focus on narrative development, application strategy, and specialty alignment.

You bring the problem. We bring clinical, scientific, and training experience to build a clear path forward.